![Theresa Devins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Theresa Devins is Vice President-Clinical Operations at Cognition Therapeutics, Inc. since 2024.
Formerly, Dr. Devins was Director-Clinical Operations at Eisai, Inc.
Cargos activos de Theresa Devins
| Empresas | Cargo | Inicio |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2024 |
Antiguos cargos conocidos de Theresa Devins.
| Empresas | Cargo | Fin |
|---|---|---|
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
4
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
- Bolsa de valores
- Insiders
- Theresa Devins
